Publication | Closed Access

Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen study

First Line ChemotherapyOncologyGastrointestinal OncologyMedicineColorectal CancerMetastatic Colorectal CancerMetronomic ChemotherapyCancer TreatmentPharmacologyRadiation OncologyCancer Research